Article (Scientific journals)
Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseases
Guéders, Maud; Foidart, Jean-Michel; Noël, Agnès et al.
2006In European Journal of Pharmacology, 533 (1-3), p. 133-144
Peer Reviewed verified by ORBi
 

Files


Full Text
Gueders M EJP 2006.pdf.pdf
Author postprint (221.13 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
matrix metalloproteinase; tissue inhibitor of MMP; asthma; cytokine; growth factors
Abstract :
[en] In healthy lung, Matrix Metalloproteinases (MMPs) and their physiological inhibitors, tissue inhibitors of matrix metalloproteinases (TIMPs), are produced in the respiratory tract by a panel of different structural cells. These activities are mandatory for many physiological processes including development, wound healing and cell trafficking. Deregulation of proteolytic-antiproteolytic network and inappropriate secretion of various MMPs by stimulated structural or inflammatory cells is thought to take part to pathophysiology of numerous lung diseases including asthma, chronic obstructive pulmonary disease (COPD), lung fibrosis and lung cancer. Cytokines and growth factors are involved in these inflammatory processes and some of those mediators interact directly with MMPs and TIMPs leading either to a regulation of their expression or changes in their biological activities by proteolytic cleavage. In turn, cytokines and growth factors modulate secretion of MMPs establishing a complex network of reciprocal interactions. Every MMP seem to play a rather specific role and some variations of their expression are observed in different lung diseases. The precise role of these enzymes and their inhibitors is now studied in depth as they could represent relevant therapeutic targets for many diseases. Indeed, MMP inhibition can lead either to a decrease of the intensity of a pathological process or, in the contrary for some of them, to an increase of disease severity. In this review, we focus on the role played by MMPs and TIMPs in asthma and we provide an overview of their potential roles in COPD, lung fibrosis and lung cancer, with a special emphasis on loops including MMPs and cytokines and growth factors relevant in these diseases.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Guéders, Maud ;  Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Foidart, Jean-Michel ;  Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Noël, Agnès ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme
Cataldo, Didier  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et path.
Language :
English
Title :
Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseases
Publication date :
08 March 2006
Journal title :
European Journal of Pharmacology
ISSN :
0014-2999
Publisher :
Elsevier Science Bv, Amsterdam, Netherlands
Volume :
533
Issue :
1-3
Pages :
133-144
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 10 April 2009

Statistics


Number of views
393 (4 by ULiège)
Number of downloads
1019 (2 by ULiège)

Scopus citations®
 
264
Scopus citations®
without self-citations
258
OpenCitations
 
211

Bibliography


Similar publications



Contact ORBi